The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Metabolism of immune cells in cancer
Open accessAbstract
Through the successes of checkpoint blockade and adoptive cellular therapy, immunotherapy has become an established treatment modality for cancer. Cellular metabolism has emerged as a critical determinant of the viability and function of both cancer cells and immune cells. In order to sustain prodigious anabolic needs, tumours employ a specialized metabolism that differs from untransformed somatic cells. This metabolism leads to a tumour microenvironment that is commonly acidic, hypoxic and/or depleted of critical nutrients required by immune cells. In this context, tumour metabolism itself is a checkpoint that can limit immune-mediated tumour destruction. Because our understanding of immune cell metabolism and cancer metabolism has grown significantly in the past decade, we are on the cusp of being able to unravel the interaction of cancer cell metabolism and immune metabolism in therapeutically meaningful ways. Although there are metabolic processes that are seemingly fundamental to both cancer and responding immune cells, metabolic heterogeneity and plasticity may serve to distinguish the two. As such, understanding the differential metabolic requirements of the diverse cells that comprise an immune response to cancer offers an opportunity to selectively regulate immune cell function. Such a nuanced evaluation of cancer and immune metabolism can uncover metabolic vulnerabilities and therapeutic windows upon which to intervene for enhanced immunotherapy. This Review discusses our current understanding of adaptive and innate immune cell metabolism in the context of the tumour microenvironment, providing insight into the interaction of cancer cell metabolism and immune metabolism, as well as the potential for leveraging metabolic vulnerabilities to enhance the antitumour immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, HIF-2α directly upregulates PD-L1 expression by binding to the HRE in the PD-L1 promoter in ccRCC cells (Fig. 2C) [73].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [73]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
Moon, J.-S., Hisata, S., Park, M. A., DeNicola, G. M., Ryter, S. W., Nakahira, K., & Choi, A. M. K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.046 · Cited by 379
Retracted5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I. E., Conway, S. J., Marshall, B., Brown, C. C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,589
Cited by
Sorted by citations
Items 401–500 of 899
The Metabolic Relationship Between Viral Infection and Cancer
Mullen, P. J., & Christofk, H. R. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070120-090423 · Cited by 14
Qiang, W., Dai, Y., Xing, X., & Sun, X. (2022) · Cancer Medicine · doi:10.1002/cam4.4670 · Cited by 12
Zhang, D., Lu, P., Zhu, K., Wu, H., & Dai, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.724437 · Cited by 11
Yi, Z., Kou, J., Li, W., Wang, Y., Su, X., & Zhang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1595176 · Cited by 15
Chen, K., Wang, W., Shu, H.-Y., Lyu, J., Cui, W., & Fang, H. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.70054 · Cited by 11
Li, W., Li, G., Luo, C.-S., Yu, Q., & Cui, M. (2025) · Cancer Management and Research · doi:10.2147/cmar.s537930 · Cited by 11
Ryabova, A. V., Romanishkin, I. D., Skobeltsin, A., Markova, I., Pominova, D. V., Linkov, K. G., & Loschenov, V. B. (2022) · Photonics · doi:10.3390/photonics9120961 · Cited by 11
Izosimova, A. V., Mozherov, A. M., Shirmanova, M. V., Shcheslavskiy, V. I., Sachkova, D. A., Вадимовна, З. Е., Sharonov, G. V., & Yuzhakova, D. V. (2023) · Современные технологии в медицине · doi:10.17691/stm2023.15.3.01 · Cited by 11
Fu, B., Hu, J., Yu, A., & Wang, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202307823 · Cited by 12
Chen, J., Chen, R., & Huang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1372432 · Cited by 11
Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models
Boreel, D. F., Beerkens, A. P. M., Heskamp, S., Boswinkel, M., Peters, J. P. W., Adema, G. J., Span, P. N., & Bussink, J. (2024) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2024.100875 · Cited by 11
Immunometabolism in head and neck squamous cell carcinoma: Hope and challenge
Zhang, Y.-J.-N., Xiao, Y., Li, Z., & Bu, L. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167629 · Cited by 11
Tao, S., Wang, H., Ji, Q., Yang, Y., Wei, G., Li, R., & Zhou, B. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010097 · Cited by 11
PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion
Qin, W., Duan, Y., Hu, Z., Hou, Y., Wen, T., Ouyang, Y., Wang, Z., Sun, X. L., Chen, X., Wang, K. L., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20240902 · Cited by 12
Li, X., Geng, S., Chen, Q., Su, B., Song, H., Zhou, J., Jia, R., Fan, H., Li, C., Wang, Y., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c03545 · Cited by 11
Li, Z., Zhang, B., Duan, S., Liu, R., Wang, Y., Wang, Y., Zhang, J., Huang, R. Y., Jiang, R., Zhang, R., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113988 · Cited by 11
Mir, R., Javid, J., Ullah, M. F., Alrdahe, S. S., Albalawi, I. A., Mustafa, S. K., Jalal, M. M., Altayar, M. A., Albalawi, A. D., Abunab, M. K., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-02945-5 · Cited by 12
Ovarian tumors orchestrate distinct cellular compositions
Bou‐Tayeh, B., & Miller, M. L. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.014 · Cited by 11
Chen, Q., Du, X., Hu, S., & Huang, Q. (2022) · BioMed Research International · doi:10.1155/2022/5092505 · Cited by 11
LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer
Zhao, T., Liu, S., Hanna, N. H., Jalal, S. I., Ding, X., Wan, J., Yan, C., & Du, H. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006272 · Cited by 11
Group-specific cellular metabolism in Medulloblastoma
Funke, V. L. E., Walter, C., Melcher, V., Wei, L., Sandmann, S., Hotfilder, M., Varghese, J., Jäger, N., Kool, M., Jones, D., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04211-6 · Cited by 11
Immunometabolism Modulation in Therapy
Monferrer, E., Sanegre, S., Vieco-Martí, I., López-Carrasco, A., Fariñas, F., Villatoro, A. J., Abanades, S., Mañes, S., de la Cruz‐Merino, L., Noguera, R., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9070798 · Cited by 12
Peng, J., Zou, D., Han, L., Yin, Z., & Hu, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.778276 · Cited by 12
Cancer suppresses mitochondrial chaperone activity in macrophages to drive immune evasion
Zhao, H., Park, J., Wang, Y., Chou, Y.-J., Li, L., Raines, L. N., Hsu, M., Lin, C.-C., Cao, W., Ouyang, Y., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02324-2 · Cited by 11
Bao, W., Qu, X., Wang, Y., Huang, D., Zhang, H., Dong, M., Sun, H., Yang, Z., & Li, X. (2026) · MedComm · doi:10.1002/mco2.70599 · Cited by 13
Crosslinked ionizable lipids reprogram dendritic cell metabolism for potent mRNA vaccination
Kim, D., Gong, N., Alameh, M., Han, E. L., Wang, H., Wang, J., Feng, E., Yoon, I., Murray, A. M., Shi, Q., et al. (2026) · Nature Materials · doi:10.1038/s41563-026-02512-x · Cited by 10
Cellular Chemical Field and Cellular Homeostasis
Cong, B., Lü, L., Wang, Q., He, T., Li, J., Xie, H., Zhang, A., & Fan, X. (2024) · Engineering · doi:10.1016/j.eng.2024.03.001 · Cited by 10
The Role and Treatment Strategies of Ammonia-Related Metabolism in Tumor Microenvironment
Ye, Q., Li, D., Zou, Y., & Yuan, Y. (2024) · Current Gene Therapy · doi:10.2174/0115665232301222240603100840 · Cited by 10
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment
Chen, J., He, G., Cai, D., Giovannetti, E., Inamura, K., Liu, S., & Ma, W. (2024) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-24-368 · Cited by 10
Zhang, X., Zou, W., Li, Z.-Q., Yu, Z.-T., Yu, S., Lin, Z., Wu, F., Liu, P., Hu, M., Liu, R., et al. (2024) · Cell Proliferation · doi:10.1111/cpr.13738 · Cited by 10
A phosphoglycerate mutase 1 allosteric inhibitor restrains TAM-mediated colon cancer progression
Wang, C., Zhang, M., Li, S., Gong, M., Luo, M., Zhang, M.-C., Zou, J.-H., Shen, N., Xu, L., Lei, H.-M., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.09.007 · Cited by 10
The regulatory role of integrin in gastric cancer tumor microenvironment and drug resistance
Wu, S., Singab, A. N. B., Lin, G., Wang, Y., Zhu, H., Yang, G., Chen, J., Li, J., Li, P., Zhao, D., et al. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.01.001 · Cited by 10
Cai, Y., Zhao, F., & Cheng, X. (2025) · Biomolecules · doi:10.3390/biom15111546 · Cited by 10
Kishk, A., Pacheco, M. P., Heurtaux, T., Sinkkonen, L., Pang, J., Fritah, S., Niclou, S. P., & Sauter, T. (2022) · Cells · doi:10.3390/cells11162486 · Cited by 10
An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation
Li, F., Chu, Q., Hu, Z., Lu, Z., Fang, C., Han, G., Fu, Y., & Li, X. (2023) · Advanced Science · doi:10.1002/advs.202207194 · Cited by 10
Label-free spatially maintained measurements of metabolic phenotypes in cells
Hu, L., Wang, N., Bryant, J. D., Liu, L., Xie, L., West, A. P., & Walsh, A. J. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1293268 · Cited by 10
Soto, M., Filbert, E. L., Yang, H. L., Starzinski, S., Starzinski, A., Gin, M., Chen, B. K., Le, P. L., Li, T., Bol, B., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0550 · Cited by 10
Yang, Q., Duan, B., Yue, J., Zhang, D., Chen, X., Shi, M., Kan, J., Li, R., Li, H., & Gan, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1444222 · Cited by 10
Fu, C., Lu, Y., Zhang, Y., Yu, M., Ma, S., & Lyu, S. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2510 · Cited by 12
Chen, W., Liu, W., Li, Y., Wang, J., Ren, Y., Wang, G., Chen, C., & Li, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.716042 · Cited by 10
Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in gastric cancer
Tao, G., Wen, X., Wang, X., & Zhou, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-35395-y · Cited by 9
Li, J., Zhang, H., Song, K., Wu, J., Li, L., Liu, Z., Xu, B., & Song, Q. (2023) · Cancer Biomarkers · doi:10.3233/cbm-230036 · Cited by 8
Zeng, Y., Wu, T., Pan, Q., & Qiao, D. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c04512 · Cited by 9
MACC1 revisited – an in-depth review of a master of metastasis
Schöpe, P. C., Torke, S., Kobelt, D., Kortüm, B., Treese, C., Dumbani, M., Güllü, N., Walther, W., & Stein, U. (2024) · Biomarker Research · doi:10.1186/s40364-024-00689-4 · Cited by 9
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
suri, C., Pande, B., Sahithi, L. S., Swarnkar, S., Khelkar, T., & Verma, H. K. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.164 · Cited by 9
Cheng, X., Zhao, H., Li, Z., Yan, L., Min, Q., Wu, Q., & Zhan, Q. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06178-y · Cited by 10
The Impact and Molecular Mechanisms of Exercise in Cancer Therapy
Sun, Y., Ma, Y., Shi, L., Liu, Y., Dong, Y., & Jin, Q. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47050374 · Cited by 11
dipol, T., Volpicella, M., Loizzo, S., Francavilla, A. L., Sgobba, M. N., Guerra, L., Grassi, A., Mattei, F., & Pierri, C. L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144791 · Cited by 9
Metabolism and epigenetics in cancer: toward personalized treatment
Zhang, X., Liu, D., Yin, S., Gao, Y., Li, X., & Wu, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1530578 · Cited by 10
Safarzadeh, S., Naghib, S. M., Takdehghan, G., Sarrami‐Forooshani, R., Roozbahani, M. H., Sharifianjazi, F., & Tavamaishvili, K. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.124245 · Cited by 10
Jia, W., Wang, J., Yang, W., Ding, Z., Liang, L., Xu, C., Feng, Y., Lv, Q., Deming, Z., Zhao, W., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012314 · Cited by 9
Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies
Zhang, T., Gao, P., & Sun, L. (2025) · MedComm – Oncology · doi:10.1002/mog2.70045 · Cited by 10
Zheng, C., Zhang, G., Xie, K., Diao, Y., Luo, C., Wang, Y., Shen, Y., & Xue, Q. (2022) · Cancers · doi:10.3390/cancers14184522 · Cited by 9
Zeng, J., Li, M., Dai, K., Zuo, B., Guo, J., & Zang, L. (2022) · Pathology & Oncology Research · doi:10.3389/pore.2022.1610643 · Cited by 9
Valvo, V., Parietti, E., Deans, K., Ahn, S. W., Park, N. R., Ferland, B., Thompson, D., Dominas, C. A., Bhagavatula, S. K., Davidson, S. M., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1032360 · Cited by 9
Levi, J., & Hong, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1113924 · Cited by 9
Glucose promoting the early embryonic development by increasing the lipid synthesis at 2-cell stage
Wang, M., Xue, J., Li, C., Qi, L., Nie, L., & Xue, Z. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1208501 · Cited by 9
RORγT agonists as immune modulators in anticancer therapy.
Pastwińska, J., Karwaciak, I., Karaś, K., Bachorz, R. A., & Ratajewski, M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189021 · Cited by 12
Recreating metabolic interactions of the tumour microenvironment
Curvello, R., Berndt, N., Hauser, S., & Loessner, D. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.12.005 · Cited by 9
Procházková, J., Kahounová, Z., Vondráček, J., & Souček, K. (2024) · Transcription · doi:10.1080/21541264.2024.2334106 · Cited by 10
Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection
Gibson, M. S., Noronha-Estima, C., & Gama‐Carvalho, M. (2022) · Genes · doi:10.3390/genes13020273 · Cited by 9
Immune-Related Long Non-coding RNA Constructs a Prognostic Signature of Ovarian Cancer
Sun, X., Li, S., Lv, X., Yan, Y., Wei, M., He, M., & Wang, X. (2021) · Biological Procedures Online · doi:10.1186/s12575-021-00161-9 · Cited by 9
Dong, X.-M., Wu, P., Cheng, L.-H., Shou, L., Dong, H., Chen, X., Gao, H.-J., Chen, J., Xiang, F., Zhang, Q., et al. (2022) · Journal of Chromatography A · doi:10.1016/j.chroma.2022.463654 · Cited by 9
Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma
Rana, P. S., Goparaju, K., & Driscoll, J. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1141851 · Cited by 10
Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections
Esperante, D., Martínez-Gutiérrez, M. I., Issa, M. E., Schcolnik‐Cabrera, A., & Mendlovic, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1251355 · Cited by 9
Integrated Machine Learning Algorithms for Stratification of Patients with Bladder Cancer
He, Y., Wei, H., Liao, S., Ou, R., Xiong, Y., Zuo, Y., & Yang, L. (2024) · Current Bioinformatics · doi:10.2174/0115748936288453240124082031 · Cited by 8
Wang, W., Li, C., Dai, Y., Wu, Q., & Yu, W. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1399679 · Cited by 8
Pandey, S., Anang, V., & Schumacher, M. M. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.07.003 · Cited by 8
Ren, H., Bai, Y., Liu, Z., Ma, C., Tao, X., Wang, Q., Lian, H., & Li, X. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.11.004 · Cited by 8
Hua, Y., Duan, N., Sun, C., Yang, F., Tian, M., Sun, Y., Zhao, S., Gong, J., Liu, Q., Huang, X., et al. (2025) · eLife · doi:10.7554/elife.103953.3 · Cited by 15
Li, Q., Meng, F., Xie, M., Nishikawa, M., Kusamori, K., Giri, A. K., Yang, L., Li, Q., Gu, H., Chen, Z., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145155 · Cited by 8
Ton, N. Q. C., & Park, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108015 · Cited by 10
Recent advances in immunotherapy for gliomas: overcoming barriers and advancing precision strategies
Jabri, A., Mhannayeh, A., Taftafa, B., Alsharif, M., Sibai, D., Alsharif, R., Abbad, T., Elsalti, A., Ahmed, Z., Salma, J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1690464 · Cited by 11
Zhou, S., Zhang, X., Lin, J., Fenfen, M., Chen, H., CHEN, J., & Luan, X. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.015 · Cited by 8
16-h fasting optimizes cancer immunotherapy in mice and humans
Chen, S., Hu, T., Zhu, K., Liu, Y., Yang, Y., Li, X., He, J., Cui, W., Chi, Z., Yu, W., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.01.015 · Cited by 8
Chen, X., Hu, C., Kim, H., Zhang, L., Zhang, Z., Liu, H., & Yoon, J. (2026) · Chemical Society Reviews · doi:10.1039/d5cs01412c · Cited by 8
Immune-and Metabolism-Associated Molecular Classification of Ovarian Cancer
Chen, Z., Jiang, W., Li, Z., Zong, Y., & Deng, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.877369 · Cited by 8
Biodegradable nanoparticles-mediated targeted drug delivery achieves trans-spatial immunotherapy
Wang, Y., Qian, M., Xie, Y., Zhang, X., Qin, Y., & Huang, R. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.11.003 · Cited by 8
Ye, M., Li, X., Chen, L., Mo, S., Liu, J., Huang, T., Luo, F., & Zhang, J. (2023) · Cancers · doi:10.3390/cancers15030592 · Cited by 10
Kimura, K., Chun, J. H., Lin, Y., Liang, Y., Jackson, T. L. B., & Huang, R. C. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285536 · Cited by 8
New sights of immunometabolism and agent progress in colitis associated colorectal cancer
Zhang, J., Chen, C., Yan, W., & Fu, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1303913 · Cited by 10
Li, J., Wei, Y., Liu, J., Cheng, S., Zhang, X., Qiu, H., Li, J., & He, C. (2024) · Bioscience Reports · doi:10.1042/bsr20231400 · Cited by 9
Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents
Sun, C., Cheng, Y., Dong, J., Hu, L., Zhang, Y., Shen, H., Zhang, G., Jiang, B., Youssouf, S. A., Min, W., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01640 · Cited by 8
Chen, N., Zong, Y., Chen, Y., Li, L., Yang, Y., Zhao, J., Zhao, X., Xie, X., Sun, X., Li, N., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03928-7 · Cited by 8
Regulation and Functions of Protumoral Unconventional T Cells in Solid Tumors
Barsac, E., Herbozo, C. D. A., Gonzalez, L., Baranek, T., Mallevaey, T., & Paget, C. (2021) · Cancers · doi:10.3390/cancers13143578 · Cited by 8
Su, D., Wang, S., Xi, Q., Lin, L., Lu, Q., Yao, Y., Xiong, Y., Wei, H., Liang, P., Lv, Y., et al. (2021) · Briefings in Functional Genomics · doi:10.1093/bfgp/elab040 · Cited by 8
Zhang, T., Zhang, C., Fu, Z., & Gao, Q. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091768 · Cited by 8
Immune Cell Metabolism and Immuno-Oncology
Patel, C. H., & Powell, J. D. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-042605 · Cited by 9
Self-citationRadiotherapy Combination: Insight from Tumor Immune Microenvironment (TIME)
Alimohammadi, M., Nazari, H. G., Alimohammadi, R., Bakhshandeh, M., Jalali, S. A., & Rezaei, N. (2023) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v15i4.13490 · Cited by 9
Imaging extracellular acidification and immune activation in cancer
Hyder, F., & Coman, D. (2021) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2021.100278 · Cited by 8
Myeloid mechano-metabolic programming restricts anti-tumor immunityPreprint
Tharp, K. M., Kersten, K., Maller, O., Timblin, G. A., Stashko, C., Canale, F. P., Hayward, M.-K., Berestjuk, I., ten Hoeve-Scott, J., Samad, B., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.14.499764 · Cited by 8
Deciphering metabolic crosstalk in context: lessons from inflammatory diseases
Verheijen, F. W., Minh, T. T. N., Chang, J., Broere, F., Zaal, E. A., & Berkers, C. R. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13588 · Cited by 8
The multifaceted roles of aldolase A in cancer: glycolysis, cytoskeleton, translation and beyond
Yu, S., Xue, Y., Chen, Y., Cao, Y. Q., Yang, Y., Ge, X., & Cai, X. (2025) · Human Cell · doi:10.1007/s13577-025-01172-4 · Cited by 7
MultiOmics analysis of metabolic dysregulation and immune features in breast cancer
Zhou, Z.-Y., Bai, N., Zheng, W., & Ni, S. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114376 · Cited by 7
Tognetti, M., Chatterjee, L., Beaton, N., Skłodowski, K., Bruderer, R., Reiter, L., & Messner, C. B. (2025) · iScience · doi:10.1016/j.isci.2025.112230 · Cited by 8
Breaking Glycolysis Barriers to Immunotherapy with Nanomedicines
Zhang, M., Ren, Y., Li, J., Yu, J., Li, Q., Zhao, H., Wang, Z., Chen, X. S., & Cheng, J. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00042 · Cited by 9
Shaping immunotherapy through the tumor microenvironment: Translational perspectives
Vohra, V., Dhanawat, M., Chalotra, R., Bhushan, B., Garima, Girdhar, J., Madar, I. H., Singh, R., & Fareed, M. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105169 · Cited by 7
Abikenari, M. A., Nageeb, G., Ha, J. H., Sjöholm, M., Liu, J., Bergsneider, B. H.-L., Valenzuela, J., Poe, J., Cho, K. B., Verma, R., et al. (2026) · Metabolites · doi:10.3390/metabo16030185 · Cited by 9
The Role of Hypoxia in Brain Tumor Immune Responses
Park, J. H., & Lee, H. K. (2023) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2022.0043 · Cited by 8
Suresh, P. K., Banerjee, A., & Singh, P. (2023) · OpenNano · doi:10.1016/j.onano.2023.100134 · Cited by 7
Metadata
- Authors
- Leone, R. D., & Powell, J. D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Powell, Jonathan D.
- Venue
- Nature Reviews Cancer
- Published
- 2020-07-06
- Volume
- 20
- Issue
- 9
- Pages
- 516-531
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC8041116
- OpenAlex
- W3040651070
- Semantic Scholar
- 9e54633c23933564226222b58eee14bffccca97c
- Cited by
- 877
- References
- 228
- Citations by year
- 2026: 137 · 2025: 168 · 2024: 141 · 2023: 135 · 2022: 185 · 2021: 98 · 2020: 12
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA229451, R01CA226765)
- National Institute of Allergy and Infectious Diseases (R01AI077610)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- immune cell metabolism, cancer metabolism, tumor microenvironment, tumor acidosis, tumor hypoxia, nutrient depletion, adaptive immunity, innate immunity, metabolic heterogeneity, metabolic plasticity, metabolic vulnerability, immunotherapy, antitumor immunity
- MeSH terms
- Animals, Humans, Immune System, Immunotherapy, Neoplasms, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
